Application of Traditional Chinese Medicine injection in treatment of primary liver cancer: a review

Journal of Traditional Chinese Medicine

Volumn 32, Issue 3, 2012, Pages 299-307

  Li, Mouduo ^a,b   Qiao, Cuixia ^a,b   Qin, Liping ^a   Zhang, Junyong ^a   Ling, Changquan ^a,b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Carcinoma; Hepatocellular; Traditional Chinese Medicine injection

Indexed keywords

ARTICLE; BONE MARROW SUPPRESSION; CANCER GROWTH; CANCER SURVIVAL; CANCER THERAPY; CHINESE MEDICINE; DATA BASE; HUMAN; IMMUNITY; LIVER CANCER; QUALITY OF LIFE; SYMPTOM; INJECTION; LIVER TUMOR; MULTIMODALITY CANCER THERAPY; REVIEW; ABDOMINAL DISTENSION; ANOREXIA; ANTINEOPLASTIC ACTIVITY; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER REGRESSION; CANCER SURGERY; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHEMOEMBOLIZATION; COCHRANE LIBRARY; FATIGUE; FEVER; INFORMATION RETRIEVAL; KARNOFSKY PERFORMANCE STATUS; KIDNEY DYSFUNCTION; LEUKOCYTE COUNT; LEUKOCYTOSIS; LIVER DYSFUNCTION; LIVER PAIN; MEDLINE; MONOTHERAPY; NAUSEA; RADIOFREQUENCY ABLATION; SALVIA MILTIORRHIZA; SURVIVAL RATE; THROMBOCYTOPENIA; VOMITING;

HERBACEOUS AGENT; AIDI ZHUSHEYE; ANTINEOPLASTIC AGENT; ARSENIC TRIOXIDE; BRUCEA JAVANICA OIL EMULSION; CHINESE DRUG; CISPLATIN; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; FUFANG DANSHEN ZHUSHEYE; HUACHANSU ZHUSHEYE; INTERFERON; KANG AI ZHUSHEYE; KANGLALITE ZHUSHEYE; LIPID EMULSION; MELOXICAM; SHENFU ZHUSHEYE; SHENG MAI ZHUSHEYE; SHENQIFUZHENG ZHUSHEYE; SOPHORAE FLAVESCENTIS; UNCLASSIFIED DRUG; XIAO AIPING ZHUSHEYE;

COMBINED MODALITY THERAPY; DRUGS, CHINESE HERBAL; HUMANS; INJECTIONS; LIVER NEOPLASMS;

MLCS; MLOWN;

EID: 84873449507     PISSN: 02552922     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0254-6272(13)60029-1     Document Type: Article

References (62)

1. Chen J G, Song X M. Estimation and analysis of level of hepatocellular carcinoma in China. Zhongguo Zhong Liu 2005; 14(1): 28-31.
2. Chen H Y, Chen Z. Transcatheter arterial chemoembolization combined with other therapies for the treatment of primary hepatic carcinoma: review. Zhong Xi Yi Jie He Xue Bao 2008; 6(4): 422-426.
3. Guan C N, Cai L Z, Yue L Q, Zhang Y. Clinical study on treatment of advanced primary liver cancer by Yanshu Injection combining with chemotherapy. Zhongguo Zhong Yao Za Zhi 2006; 31(6): 510-512.
4. Hu YJ, Li L, Gong S X. Regulatory effect of Astragalus Injection on Th1/Th2 cell function in patients with cervical cancer. Zhongguo Zhong Xi Yi Jie He Za Zhi 2010; 30(11): 1157-1159.
5. Wang J, Jin Y, Xu Z, Zheng Z, Wan S. Involvement of caspase-3 activity and survivin downregulation in cinobufocini- induced apoptosis in A 549 cells. Exp Biol Med (Maywood) 2009; 234(5): 566-572.
6. Liu L, Chen B A, Qin S K. Anti-angiogenesis effect of arsenic trioxide plus cinobufacin on human hepatocarcinoma transplantation model nude mice. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2011; 31(1): 67-72.
7. Ding X M, Wu C J, Wang H P. Observation on effect of the therapy of primary liver cancer treated with TACE in combination with Brucea Javanica Oil Emulsion Injection. Zhongguo Wu Zhen Xue Za Zhi 2008; 8(14): 3314-3315.
8. Li X Z, Jiang S L, Wang Y, Wang L Q. Clinical observation on therapy of primary liver cancer treated with Brucea Javanica Oil Emulsion Injection in combination with TACE. Zhong Liu Ji Chu Yu Lin Chuang 2010; 23(2): 146-148.
9. Tian H Q, Li H L, Liang G W, et al. Curative effect analysis of therapy of primary liver cancer of different age groups treated with TACE with Brucea Javanica Oil Emulsion Injection. Guangming Zhong Yi 2008; 23(12): 1888-1890.
10. You J L, Wu S J, Ni Y Q, Hu P P. Therapy of primary liver cancer treated with Brucea Javanica Oil Emulsion Injection in combination with percutaneous ethanol injection. Hubei Zhong Yi 2001; 23(8): 9-10.
11. Yuan HY, Xiao XH, Huang H. Clinical observation on therapy of mid-late stage liver cancer treated with Aidi Injection in combination with TACE. Jiangxi Yi Yao 2010; 45(6): 560-561.
12. Long J A, Li Y M. Observation on therapy of 68 cases of primary liver cancer in period II and III treated with Aidi Injection in combination with TACE and chemotherapy. Hebei Yi Xue 2006; 12(3): 251-252.
13. Xue Q, Lu L Q, Yuan G R, Zhao T W. Clinical study on therapy of 32 cases of mid-late stage liver cancer treated with Cinobufacini Injection in combination with TACE. Jiangsu Zhong Yi Yao 2010; 42(2): 22-23.
14. Li Q, Sun B M, Peng Y H, Fan Z Z, Sun Y. Clinical study on therapy of liver cancer treated with Cinobufacini Injection in combination with TACE. Shanghai Zhong Yi Yao Da Xue Xue Bao 2008; 22(2): 32-34.
15. Dong H T, Zhao W, Lu W P, He Y H. Clinical observation on therapy of 38 cases of primary liver cancer treated with Cinobufacini Injection in combination with TACE. Zhongguo Zhong Yi Yao Xin Xi Za Zhi 2008; 15(3): 66-67.
16. Yu Q T, Meng Z B. Clinical study on therapy of mid-late stage liver cancer treated with Cinobufacini Injection in combination with TACE. Guangxi Zhong Yi Xue Yuan Xue Bao 2004; 7(3): 35-37.
17. Chen M X, Zhang H, Zhang Z F, Cao J X, Xu L C. Clinical observation on therapy of neoplastic fever of primary liver cancer treated with Cinobufacini Injection after TACE. Zhongguo Zhong Yi Ji Zheng 2005; 14(3): 217.
18. Qi X J, Zhao H D, Gao W B, Yin L W. Intratumor injection with Arsenic Trioxide Injection in combination with TACE in treating liver cancer. Zhong Liu Xue Za Zhi 2003; 9(3): 147-149.
19. Cui S Z, Wu Y B, Wang J K, et al. Study on therapy of liver cancer treated with Arsenic Trioxide Injection hepatic arterial infusion. Xian Dai Lin Chuang Yi Xue Sheng Wu Gong Cheng Xue Za Zhi 2006; 12(5): 433-435.
20. Hu J B, Weng J, Liu S L, Guan L L, Zhou J, Li Y J. Observation on the effect of the therapy of mid-late stage liver cancer treated with Kang-Lai-Te Injection in combination with TACE. Shanxi Zhong Liu Yi Xue 2003; 11(1): 48-49.
21. Zhu X F. Therapy of mid-late stage primary liver cancer treated with Kang-Lai-Te Injection in combination with TACE. Zhong Liu Ji Chu Yu Lin Chuang 2006; 19(2): 132-134.
22. Lu H, Zhou J S, Xu X, Deng N. Observation on the effect of the therapy of mid-late stage primary liver cancer treated with Kang-Lai-Te Injection in combination with TACE. Zhong Yuan Yi Kan 2006; 33(23): 3-4.
23. Zhang B N, Wei Z P. Study on effect by Shen Fu Injection to the quality of life of liver cancer after TACE. Shandong Yi Yao 2009; 49(24): 103.
24. Zhang W, Jin W, Ye M, Ni S M. Effect of Shen Qi Fu Zheng Injection on T-lymphocyte subsets of primary liver cancer treated after TACE. Yi Yao Dao Bao 2009; 28(2): 213-214.
25. Du Z Q, Jiang L J, Zhang Z C, Qin J Y, Lu J S. Effect of Cinobufotalin Injection and Sheng Mai Injection on immune function of liver cancer in combination with cryocare surgical system. Shi Yong Yi Xue Za Zhi 2009; 25(2): 302-304.
26. Shang A L, Li J X. Therapy of 31 cases of malignancy treated with Cinobufacini Injection in combination with radiotherapy. Zhongguo Min Jian Liao Fa 2003; 11(8): 36-37.
27. Lu Z P, Luo H S, Zhang F C. Therapy of mid-late stage liver cancer treated with Kang-Lai-Te Injection in combination with three dimensional conformal radiotherapy. Zhongguo Yi Xue Wen Zhai 2007; 16(1): 40-43.
28. Guo Z J, Lin J J, Jin C N, Zhong Y S. Clinical observation on therapy of primary liver cancer treated with Aidi Injection in combination with microwave coagulation under ultrasound guidance. Zhong Yi Yao Tong Bao 2006; 5(6): 51-54.
29. Yue Z D, Zhou L, Liu F Q, Zhao H W, Wang L. Clinical study on therapy of primary liver cancer treated with Aidi Injection in combination with radiofrequency ablation under computed tomography. Zhong Yao Yao Li Yu Lin Chuang 2010; 26(2): 77-79.
30. Xie X P, Chen P, Zhu H J, Lu H B, Zhuo D B. Clinical study of primary liver cancer by Aidi Injection combined with radiofrequency ablation. Zhongguo Xian Dai Yi Xue Za Zhi 2010; 20(12): 1857-1859.
31. Lin J J, Jin C N, Zheng J X, Dai X H. Clinical observation on therapy of primary liver cancer treated with Kang Ai Injection in combination with radiofrequency ablation. Guangming Zhong Yi 2009; 24(10): 1887-1889.
32. Lou H Z, Pan H M, Jin W. Clinical study on treatment of primary liver cancer by Aidi Injection combined with cool-tip radiofrequency ablation. Zhongguo Zhong Xi Yi jie He Za Zhi 2007; 27(5): 393-5.
33. Li Q X, Liu B, Lu P T, Ren C Y, Zhang H Z, Zheng X. Observation on the effect of the therapy of primary liver cancer treated with Shen Qi Fu Zheng Injection in combination with gamma knife. He Bei Yi Ke Da Xue Xue Bao 2006; 27(5): 424-426.
34. Wang W R, Cui S D, Zeng L M. Clinical observation on treatment of mid-advanced patients with hepatocarcinoma by Xiao'aiping Injection combined with ultrasound guided percutaneous radio-frequency. Zhongguo Zhong Xi Yi jie He Za Zhi 2003; 23(1): 19-21.
35. Zhang C Z, Wang J S. Clinical observation of primary liver cancer treated with Aidi Injection combined with little dose chemotherapy. Zhong Liu Ji Chu Yu Lin Chuang 2007; 20(2): 143-144.
36. Liang J W, Deng M H, Wei W H. Clinical observation on therapy of mid-late stage liver cancer treated with Aidi Injection in combination with meloxicam. Xian Dai Yi Yao Wei Sheng 2006; 22(16): 2461-2462.
37. Huang X H, Lin L R, Xie X J. Clinical observation on therapy of mid-late stage liver cancer treated with Aidi Injection after chemotherapy with fluorouracil. Lin Chuang Gan Dan Bing Za Zhi 2002; 18(6): 368-369.
38. Liu G D, Xiao G L. Effects of Shengqi Fuzheng Injection combined chemotherapy on patients with primary liver cancer. Xian Dai Sheng Wu Yi Xue Jin Zhan 2010; 10(7): 1348-1350.
39. Lai Y Q, Jin Y, Chen Y Y. Clinical analysis of therapy of mid-late stage liver cancer treated with Cinobufacini Injection in combination with chemotherapy. Shaanxi Zhong Liu Yi Xue 2002; 10(3): 217.
40. Xu X H, Su J, Fu X Y. Clinical observation of therapy of mid-late stage primary liver cancer treated with Kang-Lai-Te Injection in combination with capecitabine. Shi Zhen Guo Yi Guo Yao 2010; 21(6): 1479-1480.
41. Chen Y L, Li P X. Clinical effect observation of Composite Sophorae Flavescentis Injection combining with chemotherapy on treating liver cancer. Tianjin Zhong Yi Yao Da Xue Xue Bao 2006; 25(3): 166-167.
42. Qian Y, He Y K, Li J H. Clinical evaluation of liver cancer with cancerous ascites treated by Composite Sophorae Flavescentis Injection combining with chemotherapy drugs intra-abdominal injection. Nei Mongol Zhong Yi Yao 2008; 12: 13-14.
43. Huang Z F, Wei J S, Tan Z Q, Li H Z. Clinical observation on ascites due to hepatic cancer treated by Pound Danshen Injection combined with dopamine and lasix. Zhong Xi Yi Jie He Gan Bing Za Zhi 2001; 11(1): 3-4.
44. Li J D, Dai Y, Peng Y, Peng X Y, Yang H F, Wang X F. Effect of Shen Fu Injection on recovery of liver function and immunologic function after operation of liver cancer. Yi Yao Dao Bao 2009; 28(10): 1292-1294.
45. Fu X B, Han H B, Fu Q C, Hao Z Q, Liu Y F. Observation on Kang-ai Injection in the perioperative treatment of primary hepatic carcinoma. Zhongguo Zhong Liu Lin Chuang Yu Kang Fu 2010; 17(1): 95-97.
46. Chen Z, Zhai X F, Su Y H, et al. Clinical observation of Cinobufacini Injection used to treat moderate and advanced primary liver cancer. Zhong Xi Yi Jie He Xue Bao 2003; 1(3): 184-186.
47. Ma Y J, Ma Y P. Cinobufacini Injection treatment of advanced primary liver cancer clinical observation. Liaoning Zhong Yi Yao Da Xue Xue Bao 2010; 12(1): 123-124.
48. He C B, Sun C Z. Observation on therapy of 30 cases of mid-late stage liver cancer treated with Composite Sophorae Flavescentis Injection. Shandong Yi Yao 2010; 50(25): 23.
49. Tan Z Y. Observation on the curative effect of the Therapy of 35 cases of liver cancer with cancerous ascites treated with Composite Sophorae Flavescentis Injection. Shandong Yi Yao 2010; 50(45): 20.
50. Qian J, Qin S, He Z. Arsenic Trioxide Injection in the treatment of advanced primary liver and gallbladder cancer. Zhonghua Zhong Liu Za Zhi 2001; 23(6): 487-489.
51. Jiang W, Feng J F, Pan L T, Huang X E, Chen J. A clinical study of Arsenic Trioxide Injection in treatment of advanced primary carcinoma of the liver. Zhong Liu Ji Chu Yu Lin Chuang 2006; 19(1): 21-23.
52. He G J, Zhang Q A, Guo R H. Observation on the therapy of late stage liver cancer treated with Aidi Injection. Shi Yong lin Chuang Yi Yao Za Zhi 2005; 9(8): 61-62.
53. Huang L P. Observation on the curative effect of the therapy of late stage liver cancer treated with Aidi Injection. Shi Yong Zhong Xi Yi Jie He Lin Chuang 2008; 8(1): 35.
54. Chen M. Clinical observation of therapy of late stage liver cancer treated with Arsenic Trioxide Injection in combination with Aidi Injection. Hebei Yi Yao 2010; 32(15): 2027-2028.
55. Wu D H, Chen N J, Chen Y Y, Lai Y Q. Clinical observation on the therapy of mid-late stage liver cancer treated with Kang-Lai-Te Injection. Lin Chuang Yi Yao Shi Jian 2009; 18(9): 2041-2042.
56. Bai Z P, Deng X S. Effect of Oleum Fructus Brucease Injection via bronchial arterial infusion in treating advanced lung cancer. Zhongguo Zhong Xi Yi Jie He Za Zhi 2010; 30(8): 838-840.
57. Chen Y Z, Li Z D, Gao F, Zhang Y, Sun H, Li P P. Effects of combined Chinese drugs and chemotherapy in treating advanced non-small cell lung cancer. Chin J Integr Med 2009; 15(6): 415-419.
58. Wu W Y, Long S Q, Zhang H B, et al. Improvement of quality of life with ShenFu Injection in non small cell lung cancer patients treated with gemcitabine plus cisplatin regimen. Chin J Integr Med 2006; 12(1): 50-54.
59. Liu X, Hua B J. Effect of traditional Chinese medicine on quality of life and survival period in patients with progressive gastric cancer. Zhongguo Zhong Xi Yi Jie He Za Zhi 2008; 28(2): 105-107.
60. Qi F, Li A, Inagaki Y, Gao J, Li J, Kokudo N, Li X K, Tang W. Chinese herbal medicines as adjuvant treatment during chemo- or radio-therapy for cancer. Biosci Trends 2010; 4(6): 297-307.
61. Dong J, Su S Y, Wang M Y, Zhan Z. ShenQi FuZheng, an injection concocted from Chinese medicinal herbs, combined with platinum-based chemotherapy for advanced non-small cell lung cancer: a systematic review. J Exp Clin Cancer Res 2010; 22; 29: 137.
62. Peng X, Zhao Y, Liang X, Wu L, Cui S, Guo A, Wang W. Assessing the quality of RCTs on the effect of beta-elemene, one ingredient of a Chinese herb, against malignant tumors. Contemp Clin Trials 2006; 27(1): 70-82